Insider Trading: Albany Molecular Research Inc (AMRI.O)

AMRI.O on Nasdaq

11.97USD
18 Jun 2013
Price Change (% chg)

$-0.13 (-1.07%)
Prev Close
$12.10
Open
$12.10
Day's High
$12.22
Day's Low
$11.76
Volume
211,435
Avg. Vol
422,814
52-wk High
$12.50
52-wk Low
$2.41

Search Stocks
HAGEN STEVEN R Options Exercised: 0
Trade Date: Sunday, 18 Mar 2012 Price: 2.75
Title: Officer Shares Held: 36,396
Type Traded: Direct Net Change in Shares This Filing: -1,078
» More Insider Trading

Institutional Holders

% Shares Owned: 71.62%
# of Holders: 102
Total Shares Held: 22,501,176
3 Mo. Net Change: 7,093,905
# New Positions: 29
# Closed Positions: 13
# Increased Positions: 62
# Reduced Positions: 32
# Net Buyers: 30

Officers & Directors

Name Age Since Current Position

William Marth

 58 2013 Chairman of the Board

Thomas D' Ambra

 57 2013 President, Chief Executive Officer, Director

Michael Nolan

 48 2012 Chief Financial Officer, Vice President, Treasurer

Steven Hagen

 52 2012 Senior Vice President - Pharmaceutical Development and Manufacturing

Bruce Sargent

 59 Senior Vice President - Drug Discovery

Lori Henderson

 51 2011 Vice President, General Counsel, Secretary

Richard Saffee

 2013 Vice President and General Manager - Large Scale Manufacturing

Takeshi Yura

 2013 Vice President - Discovery and Development Services, Asia

Una Ryan

 71 2010 Lead Independent Director

Veronica Jordan

 62 2006 Independent Director

Gabriel Leung

 51 2010 Independent Director

Kevin O' Connor

 58 2000 Independent Director

Arthur Roth

 73 2003 Independent Director
Search Stocks